Literature DB >> 12874869

Determination of bupivacaine and metabolites in rat urine using capillary electrophoresis with mass spectrometric detection.

Ryan M Krisko1, Mark A Schieferecke, Todd D Williams, Craig E Lunte.   

Abstract

A method using capillary electrophoresis-mass spectrometry (CE-MS) was developed for the structural elucidation of bupivacaine and metabolites in rat urine. Prior to CE-MS analysis, solid-phase extraction (SPE) was used for sample cleanup and preconcentration purposes. Exact mass and tandem mass spectrometric (MS/MS) experiments were performed to obtain structural information about the unknown metabolites. Two instruments with different mass analyzers were used for mass spectrometric detection. A quadrupole time-of-flight (Q-TOF) and a magnetic sector hybrid instrument were coupled to CE and used for the analysis of urine extracts. Hydroxybupivacaine as well as five other isomerically different metabolites were detected including methoxylated bupivacaine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874869      PMCID: PMC2519815          DOI: 10.1002/elps.200305469

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  22 in total

Review 1.  Recent advances in capillary electrophoresis/electrospray-mass spectrometry.

Authors:  A von Brocke; G Nicholson; E Bayer
Journal:  Electrophoresis       Date:  2001-04       Impact factor: 3.535

2.  High-performance liquid chromatographic method for the quantitation of bupivacaine, 2,6-pipecoloxylidide and 4'-hydroxybupivacaine in plasma and urine.

Authors:  H Kastrissios; M F Hung; E J Triggs
Journal:  J Chromatogr       Date:  1992-05-20

3.  Chiral separations of basic drugs and quantitation of bupivacaine enantiomers in serum by capillary electrophoresis with modified cyclodextrin buffers.

Authors:  H Soini; M L Riekkola; M V Novotny
Journal:  J Chromatogr       Date:  1992-09-11

4.  Isolation and identification by mass spectrometry of metaboltes of bupivacaine.

Authors:  R Bouché; G Lhoest
Journal:  Pharm Acta Helv       Date:  1976

5.  Sensitive determination of bupivacaine in human plasma by high-performance liquid chromatography.

Authors:  H C Michaelis; W P Geng; G F Kahl; H Foth
Journal:  J Chromatogr       Date:  1990-04-27

6.  Simple, rapid high-performance liquid chromatographic determination of bupivacaine in human plasma.

Authors:  N W Sullivan; L Weiner
Journal:  J Chromatogr       Date:  1987-06-05

7.  Simultaneous determination of bupivacaine and its two metabolites, desbutyl- and 4'-hydroxybupivacaine, in human serum and urine.

Authors:  R L Lindberg; J H Kanto; K K Pihlajamäki
Journal:  J Chromatogr       Date:  1986-12-19

8.  Distribution, biotransformation and excretion of bupivacaine in the rat and the monkey.

Authors:  T J Goehl; J B Davenport; M J Stanley
Journal:  Xenobiotica       Date:  1973-12       Impact factor: 1.908

9.  Extradural administration of bupivacaine: pharmacokinetics and metabolism in pregnant and non-pregnant women.

Authors:  K Pihlajamäki; J Kanto; R Lindberg; M Karanko; P Kiilholma
Journal:  Br J Anaesth       Date:  1990-05       Impact factor: 9.166

10.  The use of a selected ion monitoring technique to study the disposition of bupivacaine in mother, fetus, and neonate following epidural anesthesia for cesarean section.

Authors:  P M Kuhnert; B R Kuhnert; J M Stitts; T L Gross
Journal:  Anesthesiology       Date:  1981-12       Impact factor: 7.892

View more
  1 in total

1.  Quantitative mass spectrometric analysis of ropivacaine and bupivacaine in authentic, pharmaceutical and spiked human plasma without chromatographic separation.

Authors:  Nahla N Salama; Shudong Wang
Journal:  Anal Chem Insights       Date:  2008-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.